Togo vs Zambia: Access to anti-retroviral drugs, female
Togo
96.0%
in 2024
Zambia
96.0%
in 2024
Togo rank
14th
Zambia rank
14th
Access to anti-retroviral drugs, female over time
- Togo
- Zambia
How they compare
Togo currently reports 96.0% against 96.0% in Zambia, a difference of 0.0%.
The two have swapped places 4 times across 25 shared years of data; in 2000 it was Zambia ahead.
Togo ranks 14th and Zambia ranks 14th of 141 countries.
Zambia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Togo | Zambia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.6% | 10.5% | 5.9% | Zambia |
| 2010s | 51.6% | 60.0% | 8.4% | Zambia |
| 2020s | 91.2% | 92.4% | 1.2% | Zambia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Togo or Zambia?
- Togo, at 96.0% against 96.0% in Zambia as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Togo and Zambia?
- 0.0%, with Togo ahead.
- How many years of comparable data are there for Togo and Zambia?
- 25 years are reported by both, from 2000 to 2024.
- How do Togo and Zambia rank globally for access to anti-retroviral drugs, female?
- Togo ranks 14th and Zambia ranks 14th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.